Matt Vaughan

Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei.

Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei.

Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei.

Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei.

Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei.